All articles — 4193 total
CTSH enters the post-earnings week under broad analyst pressure, with nearly every major firm trimming its price target while keeping ratings in place — a pattern that signals diminished confidence rather than outright…
CCOI is trading at $18.06 after one of its worst weeks in recent memory — a 25% collapse driven by a Q1 earnings report that sent the stock down 22% in a single session. The catalyst was May 4's Q1 2026 results.…
Clean Harbors heads into the week after its May 6 earnings release with the stock up 2.5% on the week, shorts in retreat, and a string of analyst upgrades that began well before the print. The most compelling story…
CVX heads into its May 27 Q1 results with the Street turning more constructive — but the stock's own insiders were quietly selling into that optimism earlier this spring. The analyst picture has shifted meaningfully in…
Cardinal Health heads into the first full week of May under pressure, having shed 4.2% over the past week to close at $197, while the Street digests a mixed earnings signal and a wave of freshly cut price targets. The…
CBT reported Q2 fiscal 2026 results on May 5 that beat on every line — yet short sellers used the rally to add, not reduce. That tension sits at the heart of this week's setup. Cabot's headline numbers were clean.…
CVS Health heads into its May 14 earnings call with short sellers meaningfully rebuilding positions after a multi-week retreat — the most notable repositioning on the stock this side of April. The short-interest story…
Bruker Corporation heads into the post-earnings session with a clean beat and short sellers on the back foot — the sharpest tension of the week is between a positioning structure that expected more pain and a print…
Azenta enters the post-earnings week with one of the sharpest short-interest buildups in its recent history — and the stock has barely flinched. Short sellers have been piling into AZTA at a pace that stands out even…
Boston Scientific has spent the past two weeks being repriced lower — down 11% in a month and touching a fresh 52-week low — and the central question now is whether that rerating is a correction or the start of…
SAM enters May with a compound problem: a stock down 13% in a month, options traders at near-peak defensive positioning, and every analyst on the Street still holding neutral but trimming targets in the wake of a…
BorgWarner reported Q1 2026 results today that landed cleanly ahead of estimates — and the options market had already begun pricing in a friendlier outcome. The most striking data point this week is not in the short…
BioCryst Pharmaceuticals heads into the post-earnings period with a striking bifurcation: short interest has jumped back toward cycle highs while borrowing costs have crashed to their lowest levels of the year — a…
BALL enters the week after a bruising post-earnings session that punished what was, on paper, a solid Q1 print — and the widening gap between the stock's $57.11 close and the Street's $70.79 average target tells the…
AVA enters its May 14 earnings call in a strikingly different shape than it did six weeks ago — short sellers have quietly stepped back, analysts remain split near fair value, and options traders are the most cautious…
AutoNation heads into the week with an unusual mix of signals: short sellers are rebuilding positions at their fastest pace in months, yet the Street's most active coverage is moving targets higher. Short interest has…
Astec Industries heads into its May 13 earnings report with the most bullish options positioning in a year — a sharp reversal from the deep defensive stance that defined the stock through most of April. The options…
Archer-Daniels-Midland enters its Q1 2026 earnings call — scheduled for May 7 — with the stock up 9% on the week, the Street raising targets across the board, and shorts building quietly in the background. The…
Applied Materials has spent the past week making a strong case that semiconductor equipment demand is alive and well. The stock gained nearly 8% on the week to close at $410.82 — up 5% on Tuesday alone — and the…
AAPL has had a strong week, and for once the analyst community is in a hurry to acknowledge it. The stock closed Tuesday at $284.18, up nearly 5% on the week and 11% over the past month. That recovery follows Apple's…
